American Society of Clinical Oncology Choosing Wisely; Last Reviewed 2021 ASCO's 2021 Top Five List in Oncology The American Society of Clinical Oncology (ASCO) is a medical professional oncology ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

All International Development and Education Award (IDEA) applications are carefully reviewed and evaluated by the IDEA Steering Group. The Steering Group scores and ranks the applications using ...

ASCO’s Leadership Development Program (LDP) prepares you to become a leader while giving you exclusive access to ASCO leaders and the broader oncology community, as well as a robust network of past ...

ASCO’s patient education resources are reviewed by ASCO’s Patient Information Editorial Board, composed of 200+ medical, surgical, radiation, and pediatric oncologists; multidisciplinary members of ...

The budget reconciliation bill, known as the One Big Beautiful Bill (OBBB), a broad spending and tax bill that includes significant healthcare policies, is now on its way to President Trump after ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

The 2025 ASCO Annual Meeting was funded through Conquer Cancer ®, the ASCO Foundation by these generous donors.

The purpose of this toolkit is to provide oncology professionals with the tools and resources that will assist them in effectively integrating hereditary cancer risk assessment into practice.

A new article in JCO Oncology Practice (JCO OP) looks at the root causes of cancer drug shortages in the United States (U.S.), the impact of these shortages on patients and providers, and makes ...

If you are looking for non-scientific summaries for patients, please visit the Patient Information page. TAPUR Study Analysis Plan The TAPUR Study is a phase II, non-randomized, open-label clinical ...

Update Your COI Disclosure Disclosure of Relationships with Companies The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through ...